Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schlossman

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Oncogene|August 9, 2001
The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applicationsT Hideshima, D Chauhan, R Schlossman, et al.
Journal of Virology|May 1, 1984
Localization of the simian virus 40 small t antigen in the nucleus and cytoplasm of monkey and mouse cellsM Ellman, I Bikel, J Figge, et al.
Annals of Internal Medicine|June 1, 1980
Aplastic anemia and sulindacL Bennett, R Schlossman, J Rosenthal, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignanciesS P Treon, C Mitsiades, N Mitsiades, et al.
Blood|July 27, 2001
TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applicationsC S Mitsiades, S P Treon, N Mitsiades, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2000
Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myelomaE Orsini, E P Alyea, A Chillemi, et al.
Leukemia & Lymphoma|March 1, 1995
Monoclonal antibody-purged bone marrow transplantation therapy for multiple myelomaM V Seiden, R Schlossman, J Andersen, et al.
Bone Marrow Transplantation|March 29, 2000
Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusionE Orsini, E P Alyea, R Schlossman, et al.
Blood|June 20, 1998
Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplantE P Alyea, R J Soiffer, C Canning, et al.
Oncogene|October 4, 2006
A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myelomaD Chauhan, M Velankar, M Brahmandam, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Oncogene|August 9, 2001
The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applicationsT Hideshima, D Chauhan, R Schlossman, et al.
Journal of Virology|May 1, 1984
Localization of the simian virus 40 small t antigen in the nucleus and cytoplasm of monkey and mouse cellsM Ellman, I Bikel, J Figge, et al.
Annals of Internal Medicine|June 1, 1980
Aplastic anemia and sulindacL Bennett, R Schlossman, J Rosenthal, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignanciesS P Treon, C Mitsiades, N Mitsiades, et al.
Blood|July 27, 2001
TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applicationsC S Mitsiades, S P Treon, N Mitsiades, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2000
Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myelomaE Orsini, E P Alyea, A Chillemi, et al.
Leukemia & Lymphoma|March 1, 1995
Monoclonal antibody-purged bone marrow transplantation therapy for multiple myelomaM V Seiden, R Schlossman, J Andersen, et al.
Bone Marrow Transplantation|March 29, 2000
Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusionE Orsini, E P Alyea, R Schlossman, et al.
Blood|June 20, 1998
Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplantE P Alyea, R J Soiffer, C Canning, et al.
Oncogene|October 4, 2006
A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myelomaD Chauhan, M Velankar, M Brahmandam, et al.
Pageof 3